About Emmaus Medical
Emmaus Medical is a company based in Torrance (United States) founded in 2000 was acquired by Generex Biotechnology in January 2017. It operates as a Direct-to-Consumer (D2C), and Professional Services. The company has 35 employees as of December 31, 2024. Emmaus Medical offers products and services including Endari and L-glutamine for Diverticulosis. Emmaus Medical operates in a competitive market with competitors including Nimbus Therapeutics, Escient Pharmaceuticals, Aclaris Therapeutics, Editas Medicine and Alpine Immune Sciences, among others.
- Headquarter Torrance, United States
- Employees 35 as on 31 Dec, 2024
- Stage Public
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Emmaus Life Sciences, Inc.
-
Annual Revenue
$16.65 M-43.73as on Dec 31, 2024
-
Net Profit
$-6.45 M-72.86as on Dec 31, 2024
-
EBITDA
$-1.87 M-152.41as on Dec 31, 2024
-
Latest Funding Round
$110 K (USD), Post-IPO
Jun 30, 2022
-
Investors
Generex Biotechnology
& 4 more
-
Employee Count
35
as on Dec 31, 2024
-
Acquired by
Generex Biotechnology
(Jan 16, 2017)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Emmaus Medical
Emmaus Medical is a publicly listed company on the OTC with ticker symbol EMMA in USA, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of Emmaus Medical
Emmaus Medical offers a comprehensive portfolio of products and services, including Endari and L-glutamine for Diverticulosis. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Endari is used for sickle cell disease treatment.
L-glutamine is researched for treating diverticulosis conditions.
Unlock access to complete
Unlock access to complete
Funding Insights of Emmaus Medical
- Total Funding Total Funding
- Total Rounds 14
- Last Round Post-IPO — $110,000
-
First Round
First Round
(25 Mar 2011)
- Investors Count 4
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jun, 2022 | Amount | Post-IPO - Emmaus Medical | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Emmaus Medical | Valuation |
investors |
|
| Sep, 2020 | Amount | Post-IPO - Emmaus Medical | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Emmaus Medical
Emmaus Medical has secured backing from 5 investors, including institutional and venture fund investors. Prominent investors backing the company include Generex Biotechnology, Hanil Vacuum and KPM Tech. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Founded Year | Domain | Location | |
|
Develops new drugs for pain and central nervous system diseases through R&D.
|
Founded Year | Domain | Location | |
|
Manufacturer of automatic plating equipment, brightener, grease removers, coating, and plating chemicals
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Emmaus Medical
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Emmaus Medical
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Emmaus Medical Comparisons
Competitors of Emmaus Medical
Emmaus Medical operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Nimbus Therapeutics, Escient Pharmaceuticals, Aclaris Therapeutics, Editas Medicine and Alpine Immune Sciences, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Targeted therapeutics for cancer, metabolic, and inflammatory diseases are developed.
|
|
| domain | founded_year | HQ Location |
Small molecule therapeutics for inflammatory diseases are developed.
|
|
| domain | founded_year | HQ Location |
Novel dermatologic therapies are developed for skin conditions.
|
|
| domain | founded_year | HQ Location |
Therapeutics for rare genetic diseases are developed using CRISPR technology.
|
|
| domain | founded_year | HQ Location |
Developer of immunotherapies to treat cancer and autoimmune disorders
|
|
| domain | founded_year | HQ Location |
Small molecules are developed for sickle cell disease treatment.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Emmaus Medical
Frequently Asked Questions about Emmaus Medical
When was Emmaus Medical founded?
Emmaus Medical was founded in 2000 and raised its 1st funding round 11 years after it was founded.
Where is Emmaus Medical located?
Emmaus Medical is headquartered in Torrance, United States. It is registered at Torrance, California, United States.
How many employees does Emmaus Medical have?
As of Dec 31, 2024, the latest employee count at Emmaus Medical is 35.
What is the annual revenue of Emmaus Medical?
Annual revenue of Emmaus Medical is $16.65M as on Dec 31, 2024.
What does Emmaus Medical do?
Emmaus Medical, under Emmaus Life Sciences, Inc., is focused on the discovery, development, and commercialization of innovative therapies for rare and orphan diseases, primarily sickle cell disease. Efforts are being expanded to address conditions affecting larger populations, such as diverticulosis. Solutions like Endari, an L-glutamine oral powder, are developed to manage sickle cell disease complications. Research and clinical trials are conducted to explore additional therapeutic applications of L-glutamine. The company operates in the healthcare sector, targeting unmet medical needs through biotechnological advancements.
Who are the top competitors of Emmaus Medical?
Emmaus Medical's top competitors include Escient Pharmaceuticals, Nimbus Therapeutics and Alpine Immune Sciences.
What products or services does Emmaus Medical offer?
Emmaus Medical offers Endari and L-glutamine for Diverticulosis.
Is Emmaus Medical publicly traded?
Yes, Emmaus Medical is publicly traded on OTC under the ticker symbol EMMA.
Who are Emmaus Medical's investors?
Emmaus Medical has 5 investors. Key investors include Generex Biotechnology, Hanil Vacuum, KPM Tech, Vivozon, and GPB Capital.
What is Emmaus Medical's ticker symbol?
The ticker symbol of Emmaus Medical is EMMA on OTC.